Study to Evaluate the Effect of Obicetrapib in Combination With Ezetimibe as an Adjunct to HIS Therapy
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- NewAmsterdam Pharma
- Study ID
- NCT05266586
- Phase
- PHASE2
- Status
- Completed
Conditions
- Dyslipidemias
- High Cholesterol
- Hypercholesterolemia
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- Obicetrapib — DRUGtablets
- Ezetimibe 10mg — DRUGcapsules; 10 mg ezetimibe tablets filled into capsule shells, 1 tablet per capsule.
- Obicetrapib placebo — OTHERtablets; no active ingredient
- Ezetimibe placebo — OTHERcapsules; no active ingredient
Study Details
This study will be a placebo-controlled, double-blind, randomized, phase 2 study to evaluate the efficacy, safety, and tolerability of obicetrapib 10 mg, both in combination with ezetimibe 10 mg and as monotherapy, as an adjunct to high-intensity statin therapy.
Key Dates
- Start date
- Mar 9, 2022
- Status verified
- Oct 2022
- Primary completion
- Aug 12, 2022
- Completion
- Sep 8, 2022
Study Design
- Enrollment
- 119 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Placebo Comparator: Placeboonce-daily placebo tablet and placebo capsule
- Experimental: monotherapyonce-daily obicetrapib 10 mg tablet and placebo capsule
- Experimental: combination therapyonce-daily obicetrapib 10 mg tablet and ezetimibe 10 mg capsule
Primary Outcome Measure
Mean Percent Change in Low-Density Lipoprotein Cholesterol (LDL-C) for Combination Treatment Group Compared With the Placebo Group [Friedewald] [ Time Frame: 12-weeks ]
Locations (16)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Velocity Clinical Research - Westlake d.b.a National Research Institute | Los Angeles | California | 90057 | - |
| Valley Clinical Trials, Inc. | Northridge | California | 91325 | - |
| Ocala Cardiovascular Research | Ocala | Florida | 34471 | - |
| A & R Research Group, LLC | Pembroke Pines | Florida | 33024 | - |
| Progressive Medical Research | Port Orange | Florida | 32127 | - |
| Meridian Clinical Research - Savannah, GA | Savannah | Georgia | 31406 | - |
| Velocity Clinical Research | Meridian | Idaho | 83642 | - |
| Biofortis, Inc | Addison | Illinois | 60101 | - |
| Northwest Heart Clinical Research, LLC | Arlington Heights | Illinois | 60005 | - |
| Midwest Institute for Clinical Research | Indianapolis | Indiana | 46260 | - |
| Research Integrity LLC | Owensboro | Kentucky | 42303 | - |
| Oakland Medical Research Center | Troy | Michigan | 48085 | - |
| Mercury Street Medical | Butte | Montana | 59701 | - |
| Meridian Clinical Research- Springdale, OH | Cincinnati | Ohio | 45219 | - |
| Aventiv Research, Inc. | Columbus | Ohio | 43213 | - |
| Summit Research Group, LLC | Munroe Falls | Ohio | 44240 | - |
Find similar trials in Los Angeles, CA
By research site
Velocity Clinical Research - Westlake d.b.a National Research Institute· Los Angeles, CAValley Clinical Trials, Inc.· Northridge, CAOcala Cardiovascular Research· Ocala, FLA & R Research Group, LLC· Pembroke Pines, FLProgressive Medical Research· Port Orange, FLMeridian Clinical Research - Savannah, GA· Savannah, GA
Related Studies
- Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)PHASE2 · Recruiting · Priscilla Hsue, MD · Los Angeles, California
- Military Health and Nutrition Examination StudyRecruiting · Pennington Biomedical Research Center · Fort Campbell, Kentucky
- Pharmacogenomic Informed Statin PrescribingRecruiting · VA Office of Research and Development · Indianapolis, Indiana
- Vascular Intervention Strategies Trial for Alzheimer'sPHASE2 · Not Yet Recruiting · University of Southern California · Los Angeles, California